The first group of volunteers in Switzerland received an Ebola vaccine developed by GlaxoSmithKline
The first group of volunteers in Switzerland received an Ebola vaccine developed by GlaxoSmithKline
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.